[BOM: 500124|NSE : DRREDDY] Financial Statement Analysis of DR REDDYS LABORATORIES -Jan 24,2022

Consolidated	Mar2021	Mar2020	Mar2019	Mar2018	Mar2017
Revenues	₹19,048 Cr	₹17,517 Cr	₹15,448 Cr	₹14,281 Cr	₹14,196 Cr
Expenses	₹15,178 Cr	₹15,047 Cr	₹12,270 Cr	₹11,930 Cr	₹11,724 Cr
Operating Profit (Excl OI)	₹3,870 Cr	₹2,470 Cr	₹3,178 Cr	₹2,351 Cr	₹2,472 Cr
Other Income	₹291 Cr	₹621 Cr	₹338 Cr	₹155 Cr	₹172 Cr
Interest	₹97 Cr	₹98 Cr	₹89 Cr	₹79 Cr	₹63 Cr
Depreciation	₹1,229 Cr	₹1,163 Cr	₹1,135 Cr	₹1,077 Cr	₹1,027 Cr
Profit Before Tax	₹2,836 Cr	₹1,830 Cr	₹2,292 Cr	₹1,350 Cr	₹1,554 Cr
Profit After Tax	₹1,904 Cr	₹1,970 Cr	₹1,906 Cr	₹912 Cr	₹1,257 Cr
Consolidated Net Profit	₹1,952 Cr	₹2,026 Cr	₹1,950 Cr	₹947 Cr	₹1,292 Cr
Earnings Per Share (Rs)	₹117.28	₹121.90	₹117.47	₹57.04	₹77.93
PAT Margin (%)	9.99	11.25	12.34	6.39	8.86
ROE(%)	11.53	13.38	14.42	7.40	10.20
ROCE(%)	15.24	10.81	13.41	8.21	9.77
Total Debt/Equity(x)	0.17	0.14	0.28	0.41	0.40

	Revenues
Y-o-Y	8.74 %
5 Yr CAGR	7.63 %

Years	Revenues
Mar2021	₹19,048 Cr	8.74
Mar2020	₹17,517 Cr	13.39
Mar2019	₹15,448 Cr	8.17
Mar2018	₹14,281 Cr	0.60
Mar2017	₹14,196 Cr	-

	Operating Profit
Y-o-Y	56.65 %
5 Yr CAGR	11.85 %

Years	Operating Profit
Mar2021	₹3,870 Cr	56.65
Mar2020	₹2,470 Cr	-22.27
Mar2019	₹3,178 Cr	35.17
Mar2018	₹2,351 Cr	-4.89
Mar2017	₹2,472 Cr	-

	Operating Margins
Y-o-Y	44.11 %
5 Yr CAGR	3.94 %

Years	Operating Margin%
Mar2021	20.32%	44.11
Mar2020	14.1%	-31.45
Mar2019	20.57%	24.97
Mar2018	16.46%	-5.46
Mar2017	17.41%	-

	Profit After Tax(PAT)
Y-o-Y	-3.67 %
5 Yr CAGR	10.86 %

Years	Profit After Tax
Mar2021	₹1,952 Cr	-3.67
Mar2020	₹2,026 Cr	3.90
Mar2019	₹1,950 Cr	105.96
Mar2018	₹947 Cr	-26.72
Mar2017	₹1,292 Cr	-

	PAT Margins
Y-o-Y	-11.20 %
5 Yr CAGR	3.05 %

Years	PAT Margin(%)
Mar2021	9.99 %	-11.20
Mar2020	11.25 %	-8.83
Mar2019	12.34 %	93.11
Mar2018	6.39 %	-27.88
Mar2017	8.86 %	-

	EPS
Y-o-Y	-3.79 %
5 Yr CAGR	10.76 %

Years	EPS
Mar2021	₹117	-3.79
Mar2020	₹122	3.77
Mar2019	₹117	105.94
Mar2018	₹57	-26.81
Mar2017	₹78	-

	ROCE
Y-o-Y	40.98 %
5 Yr CAGR	11.76 %

Years	ROCE
Mar2021	15.24%	40.98
Mar2020	10.81%	-19.39
Mar2019	13.41%	63.34
Mar2018	8.21%	-15.97
Mar2017	9.77%	-

BSE Indices	1W	1M	1Y
S&P BSE DIVIDEND STABILITY	-5%	2.5%	19.9%
S&P BSE 100 ESG INDEX	-6.2%	0.6%	22.8%
S&P BSE SENSEX	-6.2%	0.3%	18.4%
S&P BSE CARBONEX	-6.3%	0.3%	20.4%
S&P BSE LARGECAP	-6.3%	0.3%	20.7%
S&P BSE SENSEX50	-6.3%	0.4%	20.2%
S&P BSE 100 LARGECAP TMC	-6.4%	-0.1%	20.8%
S&P BSE 100	-6.5%	0.1%	20.7%
S&P BSE LARGE MIDCAP	-6.6%	-0.2%	21.9%
S&P BSE 200	-6.6%	-0.2%	22.6%
S&P BSE 250 LARGEMIDCAP	-6.6%	-0.3%	23.3%
MFG	-6.7%	-0.4%	18.9%
S&P BSE 500	-6.8%	-0.2%	24.9%
S&P BSE ALLCAP	-6.8%	-0.1%	26.1%
S&P BSE HEALTHCARE	-6.8%	-5.1%	10.7%
S&P BSE GREENEX	-6.9%	2.3%	26.8%

NSE Indices	1W	1M	1Y
NIFTY GROWTH SECTOR 15	-2.6%	2%	7.2%
NIFTY100 LOW VOLATILITY 30	-5.4%	-0.7%	15.8%
NIFTY PHARMA	-6.2%	-4.7%	2.7%
NIFTY 50	-6.3%	0.5%	20.1%
NIFTY 100	-6.4%	-0%	20.6%
NIFTY50 EQUAL WEIGHT	-6.4%	0.6%	26.6%
NIFTY 100 EQUAL WEIGHT	-6.6%	-1.1%	25%
NIFTY 200	-6.7%	-0.3%	22.5%
NIFTY HEALTHCARE	-6.7%	-5.2%	NA
NIFTY 500	-6.8%	-0.3%	24.9%
NIFTY LARGE MIDCAP 250	-7.1%	-1%	28.9%
NIFTY500 MULTICAP 50:25:25	-7.2%	-0.3%	33%

Smart-Investing.in is a D-I-Y (Do-It-Yourself) tool which helps investors make smart investment decisions using data analytics and visual charts.

Contact Us : support@smart-investing.in
Follow Us :

Useful Links
Pricing Video Course Blog

Explore
Top Gainers & Losers Quarterly Result Analysis BSE & NSE Indices

Tools
Screener Compare Analyze Portfolio

#15A, 4th Floor, City Vista, Tower A, Suite No.984, Fountain Road, Kharadi, Pune - 411014
© 2019 - 2022 Smart-Investing.in. All rights reserved. Built with ❤️ in India

Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed. We don't make any Buy/Sell recommendations and don't give any price targets. This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only. Please do your own research before making any investment decisions.

Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.

Financial Data Source: Accord Fintech | Methodology | Privacy Policy | Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 | Disclosure | Investor Charter | Lodge a Complaint | Status of Complaints | Scores portal

Data for the month ending Dec 2021

No	Received from	Average Resolution time^ (in days)
1	Directly from Investors	NA
2	SEBI(Scores)	NA
3	Other Sources(if any)	NA
	Grand Total	NA

^Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

Trend of monthly disposal of complaints

No	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Apr 2021	0	0	0	0
2	May 2021	0	0	0	0
3	Jun 2021	0	0	0	0
4	Jul 2021	0	0	0	0
5	Aug 2021	0	0	0	0
6	Sep 2021	0	0	0	0
7	Oct 2021	0	0	0	0
8	Nov 2021	0	0	0	0
9	Dec 2021	0	0	0	0
	Grand Total	0	0	0	0

*Inclusive of complaints of previous months resolved in the current month.
#Inclusive of complaints pending as on the last day of the month.

Trend of annual disposal of complaints

No	Month	Carried forward from previous year	Received	Resolved*	Pending#
2	2018-19	0	0	0	0
3	2019-20	0	0	0	0
1	2020-21	0	0	0	0
	Grand Total	0	0	0	0

*Inclusive of complaints of previous years resolved in the current year.
#Inclusive of complaints pending as on the last day of the year.

Current Share Price	:	₹4,362.4
Current MarketCap	:	₹ 72,589.5 Cr
Updated EOD on	:	Jan 24,2022

Share Price Returns(%)	1 Week	1 Month	1 Year
DR REDDYS LABORATORIES	-7%	-6%	-13.6%
SENSEX	-6.2%	0.3%	18.4%

Key Financials
Market Cap	:	₹ 72,589.5 Cr
Revenue (TTM)	:	₹ 20,442.1 Cr
Net Profit(TTM)	:	₹ 1,887.1 Cr
EPS (TTM)	:	₹ 113.4
P/E (TTM)	:	38.5

Peers & Returns	1W	1M	1Y
DR REDDYS LABORATORIES	-7%	-6%	-13.6%
SUN PHARMACEUTICAL INDUSTRIES	-5.4%	1.9%	35.7%
DIVIS LABORATORIES	-10.7%	-9.1%	14.7%
CIPLA	-1.2%	-1.8%	5.4%
GLAND PHARMA	-10.1%	-15.1%	56%
PIRAMAL ENTERPRISES	-8%	-8.2%	58.9%
CADILA HEALTHCARE	-6%	-12.5%	-15.5%
TORRENT PHARMACEUTICALS	-2.5%	2%	14.9%
ALKEM LABORATORIES	0.3%	1.1%	16.4%

DR REDDYS LABORATORIES Financial Statement Analysis [BOM: 500124|NSE : DRREDDY]

DR REDDYS LABORATORIES Share Price vs Sensex

DR REDDYS LABORATORIES Last 5 Annual Financial Results
[BOM: 500124|NSE : DRREDDY]

Key Financials

Check out Industry Peers

DR REDDYS LABORATORIES Revenues
[BOM: 500124|NSE : DRREDDY]

DR REDDYS LABORATORIES Operating Profit
[BOM: 500124|NSE : DRREDDY]

DR REDDYS LABORATORIES Profit After Tax
[BOM: 500124|NSE : DRREDDY]

DR REDDYS LABORATORIES Earnings Per Share (EPS)
[BOM: 500124|NSE : DRREDDY]

DR REDDYS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500124|NSE : DRREDDY]

DR REDDYS LABORATORIES related INDICES

You may also like the below Video Courses

FAQ [Frequently Asked Questions]

How the annual revenues of DR REDDYS LABORATORIES have changed ?

How the Earnings per Share (EPS) of DR REDDYS LABORATORIES have changed?

Disclosure

All Stocks : A - Z

DR REDDYS LABORATORIES Financial Statement Analysis [BOM: 500124\|NSE : DRREDDY]
The Revenues of DR REDDYS LABORATORIES have increased by 8.74% YoY. The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -3.79 % YoY.